Follow The Filings

ACRVAcrivon Therapeutics Inc.

Q1 2023 13F holders among managers we track Latest ownership dossier

Ticker
ACRV
Type
Equity
Class
COMMON STOCK
Total reported value (long equity)
Manager Report date Value Shares